NCT05274516View on ClinicalTrials.gov

A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

October 25, 2022

Study Completion Date

October 25, 2022

Conditions
Chronic Cough
Interventions
DRUG

HRS-2261 tablet、placebo

HRS-2261 oral tablet, oral, single dose. Matching placebo to HRS-2261, oral, single dose.

DRUG

HRS-2261 tablet、placebo

HRS-2261 oral tablet, oral, BID. Matching placebo to HRS-2261, oral, BID.

Trial Locations (1)

510120

The second hospital of Anhui Medical University, Hefei

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY